Ramelteon and Zosyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ramelteon (ramelteon) and Zosyn (piperacillin sodium; tazobactam sodium). Common drug interactions include anaemia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ramelteon and Zosyn. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ramelteon?

Ramelteon has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 1,387 Ramelteon users. Check the latest studies of Ramelteon.

What is Zosyn?

Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.



On Jul, 11, 2026

13 people who take Ramelteon and Zosyn together, and have interactions are studied.

Ramelteon and Zosyn drug interactions.

What are the common drug interactions of Ramelteon and Zosyn, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Cerebral atrophy (decrement in size of brain)
  3. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  4. Oliguria (not enough urine)
  5. Oropharyngeal candidiasis (fungal infection of oropharynx)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Device related infection
  8. Hypophagia (reduced food intake)
  9. Altered state of consciousness (altered state of mind)
  10. Catheter site infection (infection at the site of insertion)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Cerebral haemorrhage (bleeding within the brain)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Injection site reaction
  6. Myocardiac abscess (a pus containing infection of myocardium)
  7. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  8. Oral herpes (viral infection of mouth)
  9. Pericarditis (inflammation of the pericardium)
  10. Rash

What are the common drug interactions of Ramelteon and Zosyn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Anaemia (lack of blood)
  3. Hypophagia (reduced food intake)
  4. Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)
  5. Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
  6. Road traffic accident
  7. Spinal compression fracture (fracture due to spinal compression on bone)
  8. Altered state of consciousness (altered state of mind)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. C-reactive protein increased

What are the existing conditions these people have? *

  1. Rashes (redness): 3 people, 23.08%
  2. Anaplastic Astrocytoma (tumour of the glial (supportive) tissue of the brain): 3 people, 23.08%
  3. Cerebral Atrophy (decrement in size of brain): 3 people, 23.08%
  4. Dyslipidaemia (abnormal amount of lipids): 2 people, 15.38%
  5. Lung Squamous Cell Carcinoma Stage Iv (the lung cancer has spread to the other lung, and/or to lymph nodes, fluid around the lungs or heart, and/or other places in the body, such as the brain, liver, adrenal glands, kidneys, or bones): 2 people, 15.38%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 15.38%
  7. High Blood Pressure: 2 people, 15.38%
  8. Pain: 2 people, 15.38%
  9. Psoriasis (immune-mediated disease that affects the skin): 2 people, 15.38%
  10. Immunodeficiency Disorders: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Ramelteon and Zosyn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ramelteon and Zosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ramelteon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ramelteon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ramelteon and piperacillin sodium; tazobactam sodium (the active ingredients of Ramelteon and Zosyn, respectively), and Ramelteon and Zosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: